185 related articles for article (PubMed ID: 26549074)
1. Mismatch repair protein deficient endometrioid adenocarcinomas, metastasizing to adrenal gland and lymph nodes: Unusual cases with diagnostic implications.
Rekhi B
Indian J Pathol Microbiol; 2015; 58(4):491-5. PubMed ID: 26549074
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological features of 50 mismatch repair (MMR)-deficient endometrial carcinomas, tested by immunohistochemistry: A single institutional feasibility study, India.
Rekhi B; Menon S; Deodhar KK; Ghosh J; Chopra S; Maheshwari A
Ann Diagn Pathol; 2020 Aug; 47():151558. PubMed ID: 32619922
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
[TBL] [Abstract][Full Text] [Related]
4. p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.
Fadare O; Parkash V
Diagn Pathol; 2017 Nov; 12(1):81. PubMed ID: 29137657
[TBL] [Abstract][Full Text] [Related]
5. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases.
Culton LK; Deavers MT; Silva EG; Liu J; Malpica A
Am J Surg Pathol; 2006 Jul; 30(7):844-9. PubMed ID: 16819326
[TBL] [Abstract][Full Text] [Related]
6. DNA Mismatch Repair-deficient Endometrial Carcinosarcomas Portend Distinct Clinical, Morphologic, and Molecular Features Compared With Traditional Carcinosarcomas.
Segura SE; Pedra Nobre S; Hussein YR; Abu-Rustum NR; Weigelt B; Soslow RA; DeLair DF
Am J Surg Pathol; 2020 Nov; 44(11):1573-1579. PubMed ID: 32804882
[TBL] [Abstract][Full Text] [Related]
7. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
8. Mismatch repair status in high-grade endometrial carcinomas of endometrioid and non-endometrioid type.
Doulgeraki T; Vagios S; Kavoura E; Yiannou P; Messini I; Nonni A; Papadimitriou C; Vlachos A; Pavlakis K
J BUON; 2019; 24(5):2020-2027. PubMed ID: 31786870
[TBL] [Abstract][Full Text] [Related]
9. Molecular Modifiers of Hormone Receptor Action: Decreased Androgen Receptor Expression in Mismatch Repair Deficient Endometrial Endometrioid Adenocarcinoma.
Gan Q; Crumley S; Broaddus RR
Int J Gynecol Pathol; 2019 Jan; 38(1):44-51. PubMed ID: 29210800
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
[TBL] [Abstract][Full Text] [Related]
11. Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker.
Backes FJ; Haag J; Cosgrove CM; Suarez A; Cohn DE; Goodfellow PJ
Cancer; 2019 Feb; 125(3):398-405. PubMed ID: 30561762
[TBL] [Abstract][Full Text] [Related]
12. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
13. Pathological features, immunoprofile and mismatch repair protein expression status in uterine endometrioid carcinoma: focus on MELF pattern of myoinvasion.
Santoro A; Angelico G; Inzani F; Spadola S; Arciuolo D; Valente M; Musarra T; Capelli G; Fanfani F; Gallotta V; Scambia G; Zannoni GF
Eur J Surg Oncol; 2021 Feb; 47(2):338-345. PubMed ID: 32788094
[TBL] [Abstract][Full Text] [Related]
14. Does the type of surgery for early-stage endometrial cancer affect the rate of reported lymphovascular space invasion in final pathology specimens?
Momeni M; Kolev V; Cardenas-Goicoechea J; Getrajdman J; Fishman D; Chuang L; Kalir T; Rahaman J; Zakashansky K
Am J Obstet Gynecol; 2013 Jan; 208(1):71.e1-6. PubMed ID: 23099190
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report.
Yano M; Shintani D; Katoh T; Hamada M; Ito K; Kozawa E; Hasegawa K; Yasuda M
Diagn Pathol; 2019 Jun; 14(1):54. PubMed ID: 31174566
[TBL] [Abstract][Full Text] [Related]
16. Defective DNA Mismatch Repair Influences Expression of Endometrial Carcinoma Biomarkers.
Okoye EI; Bruegl AS; Fellman B; Luthra R; Broaddus RR
Int J Gynecol Pathol; 2016 Jan; 35(1):8-15. PubMed ID: 25851713
[TBL] [Abstract][Full Text] [Related]
17. Coexistent Dedifferentiated Endometrioid Carcinoma of the Uterus and Adenocarcinoma of the Bladder in Lynch Syndrome: Case Report and Review of the Literature.
Groth JV; Prabhu S; Periakaruppan R; Ohlander S; Emmadi R; Kothari R
Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):e26-e30. PubMed ID: 32167968
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of endometrioid adenocarcinoma in atypical polypoid adenomyoma.
Sonoyama A; Kanda M; Ojima Y; Kizaki T; Ohara N
Kobe J Med Sci; 2014 Dec; 60(3):E74-7. PubMed ID: 25612673
[TBL] [Abstract][Full Text] [Related]
19. High-Grade Endometrioid Carcinoma of the Endometrium With a GATA-3-Positive/PAX8-Negative Immunophenotype Metastatic to the Breast: A Potential Diagnostic Pitfall.
Salibay C; Fadare O
Int J Surg Pathol; 2020 Sep; 28(6):631-636. PubMed ID: 32188328
[TBL] [Abstract][Full Text] [Related]
20. Endometrioid carcinoma infiltrating atypical leiomyoma: a mimicker of malignant mixed Mullerian tumor.
Mahapatra QS; Ajay M; Kavita S
Indian J Pathol Microbiol; 2014; 57(2):317-9. PubMed ID: 24943777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
